Medicine Compliance Aid Stability

TavegilNovartis Pharmaceuticals UK Ltd

Novartis Pharmaceuticals UK Ltd
Tablet 1mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Store in airtight containers. Protect from light.
25 October 2022

Lactation Safety Information

Cetirizine/Loratadine. If a sedating antihistamine required chlorphenamine is preferred (see summary
Sedating antihistamine
No published evidence of safety
Case report of sedation in a breastfed infant
Monitor infant for drowsiness
3 August 2020